DocSym
β
Searchsearch
Search
(P37.3) Congenital falciparum malaria
More details coming soon
80 101 in individuals diagnosis congenital falciparum malaria confirmed
2 737 deaths with diagnosis congenital falciparum malaria
3% mortality rate associated with the disease congenital falciparum malaria
Diagnosis congenital falciparum malaria is diagnosed Women are 1.14% more likely than Men
39 595
Men receive the diagnosis congenital falciparum malaria
1 332 (3.4 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
40 506
Women receive the diagnosis congenital falciparum malaria
1 405 (3.5 %)Died from this diagnosis.
Risk Group for the Disease congenital falciparum malaria - Men and Women aged 0
In Men diagnosis is most often set at age 0-5
Less common in men the disease occurs at Age 5-95+Less common in women the disease occurs at Age 0-95+
In Women diagnosis is most often set at age 0-1
Disease Features congenital falciparum malaria
Absence or low individual and public risk
Congenital falciparum malaria - what does this mean
Congenital falciparum malaria is a rare form of malaria that is passed from mother to baby during pregnancy. it occurs when a pregnant woman is infected with the plasmodium falciparum parasite, which is transmitted by the bite of an infected mosquito. the baby is then infected in the uterus, and can experience severe health complications shortly after birth.
What happens during the disease - congenital falciparum malaria
Congenital falciparum malaria is caused by the plasmodium falciparum parasite, which is transmitted to the fetus through the placenta of an infected mother. the parasite can then invade erythrocytes, leading to anemia, organ dysfunction, and other symptoms. additionally, the parasite can adhere to the placenta, leading to placental insufficiency and fetal death.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination
- Complete blood count
- Thick and thin blood smears
- Malaria antigen tests
- PCR testing
- Serology testing
- Urine analysis
- Liver function tests
- Ultrasound imaging
- CT scan
- MRI scan
Treatment and Medical Assistance
Main goal of the treatment: To reduce the severity and duration of symptoms of congenital falciparum malaria
- Administer antimalarial medications, such as chloroquine, quinine, or artemisinin derivatives, to reduce the severity and duration of symptoms.
- Provide supportive care, such as oxygen therapy, hydration, and monitoring of vital signs.
- Monitor for signs of anemia, such as pale skin, fatigue, or shortness of breath.
- Administer antibiotics to prevent secondary bacterial infections.
- Provide nutrition and fluids to prevent dehydration.
- Provide education to the patient and family on preventive measures.
18 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Congenital falciparum malaria - Prevention
Prevention of congenital falciparum malaria involves pregnant women taking antimalarial drugs, such as chloroquine, to protect the unborn baby from infection. additionally, pregnant women should be advised to take measures to reduce their risk of malaria infection, such as using insect repellent, sleeping under a mosquito net, and avoiding areas where malaria is common.